{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:25Z","timestamp":1707524665840},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,31]]},"DOI":"10.7759\/cureus.30896","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T09:51:36Z","timestamp":1667209896000},"source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune Hepatitis Following mRNA COVID-19 Vaccination in a Very Old Patient With Preexisting Sj\u00f6gren\u2019s Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Yukinari","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril F","year":"2021","unstructured":"Bril F, Al Diffalha S, Dean M, Fettig DM. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?. J Hepatol. 2021, 75:222-4. 10.1016\/j.jhep.2021.04.003","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad A","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, et al.. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021, 9:435. 10.3390\/vaccines9050435","journal-title":"Vaccines (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100140","article-title":"COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature","volume":"5","author":"Camacho-Dom\u00ednguez L","year":"2022","unstructured":"Camacho-Dom\u00ednguez L, Rodr\u00edguez Y, Polo F, Restrepo Gutierrez JC, Zapata E, Rojas M, Anaya JM. COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature. J Transl Autoimmun. 2022, 5:100140. 10.1016\/j.jtauto.2022.100140","journal-title":"J Transl Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.03.014","article-title":"Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury","volume":"54","author":"Lleo A","year":"2022","unstructured":"Lleo A, Cazzagon N, Rigamonti C, Cabibbo G, Lai Q, Muratori L, Carbone M. Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury. Dig Liver Dis. 2022, 54:722-6. 10.1016\/j.dld.2022.03.014","journal-title":"Dig Liver Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07504-w","article-title":"Autoimmune hepatitis-like syndrome following COVID-19 vaccination: a systematic review of the literature","volume":"67","author":"Chow KW","year":"2022","unstructured":"Chow KW, Pham NV, Ibrahim BM, Hong K, Saab S. Autoimmune hepatitis-like syndrome following COVID-19 vaccination: a systematic review of the literature. Dig Dis Sci. 2022, 67:4574-80. 10.1007\/s10620-022-07504-w","journal-title":"Dig Dis Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i17.3621","article-title":"Autoimmunity as the comet tail of COVID-19 pandemic","volume":"8","author":"Talotta R","year":"2020","unstructured":"Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases. 2020, 8:3621-44. 10.12998\/wjcc.v8.i17.3621","journal-title":"World J Clin Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.4125","article-title":"Autoimmune hepatitis: recent advances in the pathogenesis and new diagnostic guidelines in Japan","volume":"54","author":"Ohira H","year":"2015","unstructured":"Ohira H, Abe K, Takahashi A, Watanabe H. Autoimmune hepatitis: recent advances in the pathogenesis and new diagnostic guidelines in Japan. Intern Med. 2015, 54:1323-8. 10.2169\/internalmedicine.54.4125","journal-title":"Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.038","article-title":"Autoimmune hepatitis following SARS-CoV-2 vaccine: may not be a casuality","volume":"75","author":"Rocco A","year":"2021","unstructured":"Rocco A, Sgamato C, Compare D, Nardone G. Autoimmune hepatitis following SARS-CoV-2 vaccine: may not be a casuality. J Hepatol. 2021, 75:728-9. 10.1016\/j.jhep.2021.05.038","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard \u00c9","year":"2021","unstructured":"Vuille-Lessard \u00c9, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021, 123:102710. 10.1016\/j.jaut.2021.102710","journal-title":"J Autoimmun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102745","article-title":"Autoimmune hepatitis after SARS-CoV-2 vaccine: new-onset or flare-up?","volume":"125","author":"Avci E","year":"2021","unstructured":"Avci E, Abasiyanik F. Autoimmune hepatitis after SARS-CoV-2 vaccine: new-onset or flare-up?. J Autoimmun. 2021, 125:102745. 10.1016\/j.jaut.2021.102745","journal-title":"J Autoimmun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani A","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020, 217:108480. 10.1016\/j.clim.2020.108480","journal-title":"Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108665","article-title":"Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\"","volume":"224","author":"Talotta R","year":"2021","unstructured":"Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to \"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases\". Clin Immunol. 2021, 224:108665. 10.1016\/j.clim.2021.108665","journal-title":"Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051190","article-title":"B cell activation and escape of tolerance checkpoints: recent insight from studying autoreactive B cells","volume":"10","author":"Bonasia CG","year":"2021","unstructured":"Bonasia CG, Abdulahad WH, Rutgers A, Heeringa P, Bos NA. B cell activation and escape of tolerance checkpoints: recent insight from studying autoreactive B cells. Cells. 2021, 10:1190. 10.3390\/cells10051190","journal-title":"Cells"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14238","article-title":"COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells","volume":"25","author":"Sachinidis A","year":"2022","unstructured":"Sachinidis A, Garyfallos A. COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells. Int J Rheum Dis. 2022, 25:83-5. 10.1111\/1756-185X.14238","journal-title":"Int J Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04433-9","article-title":"Age-associated B cells in autoimmune diseases","volume":"79","author":"Mouat IC","year":"2022","unstructured":"Mouat IC, Goldberg E, Horwitz MS. Age-associated B cells in autoimmune diseases. Cell Mol Life Sci. 2022, 79:402. 10.1007\/s00018-022-04433-9","journal-title":"Cell Mol Life Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/art.37828","article-title":"Expansion of autoreactive unresponsive CD21-\/low B cells in Sj\u00f6gren's syndrome-associated lymphoproliferation","volume":"65","author":"Saadoun D","year":"2013","unstructured":"Saadoun D, Terrier B, Bannock J, et al.. Expansion of autoreactive unresponsive CD21-\/low B cells in Sj\u00f6gren's syndrome-associated lymphoproliferation. Arthritis Rheum. 2013, 65:1085-96. 10.1002\/art.37828","journal-title":"Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks SA","year":"2018","unstructured":"Jenks SA, Cashman KS, Zumaquero E, et al.. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018, 49:725-39. 10.1016\/j.immuni.2018.08.015","journal-title":"Immunity"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32409","article-title":"Letter to the editor: liver transplantation following severe acute respiratory syndrome-coronavirus-2 vaccination-induced liver failure","volume":"75","author":"Efe C","year":"2022","unstructured":"Efe C, Harputluo\u011flu M, Soylu NK, Yilmaz S. Letter to the editor: liver transplantation following severe acute respiratory syndrome-coronavirus-2 vaccination-induced liver failure. Hepatology. 2022, 75:1669-71. 10.1002\/hep.32409","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102688","article-title":"Auto-immune hepatitis following COVID vaccination","volume":"123","author":"Rela M","year":"2021","unstructured":"Rela M, Jothimani D, Vij M, Rajakumar A, Rammohan A. Auto-immune hepatitis following COVID vaccination. J Autoimmun. 2021, 123:102688. 10.1016\/j.jaut.2021.102688","journal-title":"J Autoimmun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101841","article-title":"Autoimmune hepatitis developing after COVID 19 vaccine: presumed guilty?","volume":"46","author":"Erard D","year":"2022","unstructured":"Erard D, Villeret F, Lavrut PM, Dumortier J. Autoimmune hepatitis developing after COVID 19 vaccine: presumed guilty?. Clin Res Hepatol Gastroenterol. 2022, 46:101841. 10.1016\/j.clinre.2021.101841","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120505-autoimmune-hepatitis-following-mrna-covid-19-vaccination-in-a-very-old-patient-with-preexisting-sjgrens-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:12Z","timestamp":1707508092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120505-autoimmune-hepatitis-following-mrna-covid-19-vaccination-in-a-very-old-patient-with-preexisting-sjgrens-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.30896","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,31]]}}}